CXCR1/2 antagonists (University of Nebraska Medical Center)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameCXCR1/2 antagonists (University of Nebraska Medical Center)
Drug Alias NamesiRNA therapy (UNMC)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionC-X-C motif chemokine receptor 2 antagonistsC-X-C motif chemokine receptor 1 inhibitors
TargetsC-X-C motif chemokine receptor 2C-X-C motif chemokine receptor 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Nebraska Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Nebraska Medical Center
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A